Identifying diagnostic peptides for Lyme disease through epitope discovery

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 1, 2001, Pages 150-160

  Kouzmitcheva, G A ^a   Petrenko, V A ^a   Smith, G P ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; EPITOPE; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; BORRELIA BURGDORFERI; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYME DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; SERODIAGNOSIS; SEROPREVALENCE;

AMINO ACID SEQUENCE; ANIMALS; BORRELIA BURGDORFERI GROUP; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; HUMANS; LYME DISEASE; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES;

EID: 0035161266     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.1.150-160.2001     Document Type: Article

References (83)

1. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology
2. DNA-based selection and screening of peptide ligands
3. Diagnostic tools in Lyme borreliosis: Clinical history compared with serology
4. Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage
5. Role of serology in the diagnosis of Lyme disease
6. Development of enzyme-linked immunosorbent assays using recombinant borrelial antigens for serodiagnosis of Borrelia burgdorferi infection
7. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease
8. Problems in the use of serologic tests for the diagnosis of Lyme disease
9. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries
10. Epitope discovery using peptide libraries displayed on phage
11. Advances and pitfalls in the diagnosis of Lyme disease
12. Borrelia burgdorferi infection: Clinical diagnostic techniques
13. Improved serodiagnostic testing for Lyme disease: Results of a multicenter serologic evaluation
14. A comparison of DNA packaging in the virions of fd, Xf, and Pfl
15. Western blotting in the serodiagnosis of Lyme disease
16. Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera
17. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library
18. Structural characterization of peptides that bind synovial fluid antibodies from RA patients: A novel strategy for identification of disease-related epitopes using a random peptide library
19. Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis
20. Comparison of immunodot and Western blot assays for diagnosing Lyme borreliosis
21. Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin
22. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera
23. Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease
24. The delineation of peptides able to mimic assembled epitopes
25. A priori delineation of a peptide which mimics a discontinuous antigenic determinant
26. The Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early Lyme disease is the flaA gene product
27. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi
28. Evaluation of fifteen commercially available serological tests for diagnosis of Lyme borreliosis
29. Impact of strain heterogeneity on Lyme disease serology in Europe: Comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato
30. Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe
31. Lyme borreliosis-problems of serological diagnosis
32. Solvent/detergent-treated plasma: A virus-inactivated substitute for fresh frozen plasma
33. Screening of horse polyclonal antibodies with a random peptide library displayed on phage: Identification of ligands used as antigens in an ELISA test to detect the presence of antibodies to equine arteritis virus
34. Serodiagnosis of Lyme disease: Accuracy of a two-step approach using a flagella-based ELISA and immunoblotting
35. The hook protein of Borrelia burgdorferi, encoded by the flgE gene, is serologically recognized in Lyme disease
36. Serodiagnosis of neuroborreliosis: Comparison of reliability of three confirmatory assays
37. New laboratory guidelines for serologic diagnosis of Lyme disease: Evaluation of the two-test protocol
38. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE
39. Serodiagnosis of Lyme borreliosis by western immunoblot: Reactivity of various significant antibodies against Borrelia burgdorferi
40. Current status of laboratory diagnosis for Lyme disease
41. Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays
42. Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis
43. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis
44. Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopes
45. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage
46. Production of monoclonal antibodies against epitopes of the main coat protein of filamentous fd phages
47. Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library
48. Tight-binding inhibitory sequences against pp60 (c-src) identified using a random 15-amino-acid peptide library
49. Evaluation of nine serological tests for diagnosis of Lyme borreliosis
50. A comparative study of Western blot interpretation criteria for Lyme disease serological diagnosis in our environment
51. Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and P39 protein in patients with PCR- or culture-proven late Lyme borreliosis
52. Surveillance for Lyme disease - United States, 1992-1998
53. A library of organic landscapes on filamentous phage
54. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients
55. Lyme disease update. Current approach to early, disseminated, and late disease
56. Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease
57. Use of Western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease
58. Searching for peptide ligands with an epitope library
59. Diagnosis of Lyme borreliosis: Non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies
60. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease
61. Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-α): In vitro function and precise epitope mapping by phage epitope library
62. Selection of ligands for polyclonal antibodies from random peptide libraries: Potential identification of (auto) antigens that may trigger B and T cell responses in autoimmune diseases
63. Cross-linked filamentous phage as an affinity matrix
64. Libraries of peptides and proteins displayed on filamentous phage
65. Diagnosis and treatment of Lyme arthritis
66. Lyme disease
67. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
68. Lyme borreliosis - An overdiagnosed disease?
69. Identification of HCV core mimotopes: Improved methods for the selection and use of disease-related phage-displayed peptides
70. The Western immunoblot for Lyme disease: Determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels
71. Combinatorial search for diagnostic agents: Lyme antibody H9724 as an example
72. Laboratory evaluation in the diagnosis of Lyme disease
73. Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) Lyme vaccines in healthy adults
74. Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: Antibody persistence and effect of a booster dose at month 12
75. New Tn10 derivatives for transposon mutagenesis and for construction of lacZ operon fusions by transposition
76. Case definitions for public health surveillance
77. Asymmetric orientation of a phage coat protein in cytoplasmic membrane of Escherichia coli
78. Affinity maturation of phage-displayed peptide ligands
79. Presentation of peptide antigens as albumin conjugates for use in detection of serum antibodies by enzyme-finked immunosorbent assay
80. Multi-well ELISA based · on independent peptide antigens for antibody capture. Application to Lyme disease serodiagnosis
81. A new filamentous phage cloning vector: Fd-tet